LEDS [SemiLEDs] UPLOAD:
[]
HOLI [Hollysys Automation Technologies] 6-K: Hollysys Automation Technologies Reports Unaudited Financial Results for
[Hollysys Automation Technologies Reports Unaudited Financial Results for Fiscal Year 2013 Second Quarter Ended December 31, 2012 Q2 Financial Highlights • Quarterly revenues of $87.2 million, representing an increase of 8.6% compared to $80.3 million year over year, and a decrease of 1.0% compared to $88.1 million quarter over quarter. • Gross margin at 32.1%, as compared to 38.5% year]
TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)
[TPI Reports Second Quarter Fiscal Year 2013 Financial Results Tianyin Pharmaceutical Inc. CHENGDU, China, February 14, 2013 -- Second Quarter Fiscal Year 2013 Ended December 31, 2012 Financial Highlights: ● Revenue was $17.6 million compared with $18.2 million in 2Q12 a decrease of 3.3% year over year, ● Operating income was $2.6 million, compared with $2.1 million in 2Q12, an] [Tianyin Pharmaceutical Co., Inc. (“TPI”) Second Quarter of Fiscal Year 2013 Earnings Call February 14, 2013 Operator TPI James Tong Second Quarter Fiscal Year 2013 Ended December 31, 2012 Financial Highlights: ● Revenue totaled $17.6 million compared with $18.2 million in 2Q12, a decrease of 3.3% year over year, ● Operating income was $2.6 million, compared with $2.1 million in] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT February 14, 2013 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]
CEO [CNOOC] 6-K: (Original Filing)
[CNOOC Limited]
TPI [TIANYIN PHARMACEUTICAL] 8-K: TPI Reports Second Quarter Fiscal Year 2013 Financial
[TPI Reports Second Quarter Fiscal Year 2013 Financial Results Tianyin Pharmaceutical Inc. CHENGDU, China, February 14, 2013 -- Second Quarter Fiscal Year 2013 Ended December 31, 2012 Financial Highlights: ● Revenue was $17.6 million compared with $18.2 million in 2Q12 a decrease of 3.3% year over year, ● Operating income was $2.6 million, compared with $2.1 million in 2Q12, an] [Tianyin Pharmaceutical Co., Inc. (“TPI”) Second Quarter of Fiscal Year 2013 Earnings Call February 14, 2013 Operator TPI James Tong Second Quarter Fiscal Year 2013 Ended December 31, 2012 Financial Highlights: ● Revenue totaled $17.6 million compared with $18.2 million in 2Q12, a decrease of 3.3% year over year, ● Operating income was $2.6 million, compared with $2.1 million in] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT February 14, 2013 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]
CEO [CNOOC] 6-K: CNOOC Limited
[CNOOC Limited]
LFC [CHINA LIFE INSURANCE CO] 6-K: (Original Filing)
[CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the Peoples Republic of China with limited liability) (Stock Code: 2628) ANNOUNCEMENT OF THE RESOLUTIONS PASSED AT THE FIRST EXTRAORDINARY GENERAL MEETING 2013 Board Company EGM The board of directors (the The EGM was held on Tuesday, 19 February 2013 at 10:00 a.m. at Multi-function Hall, 2/F,] [China Life Appoints New Auditor (Beijing, China, February 19, 2013) The board of directors (the Board) of China Life Insurance Company Limited (the Company) (NYSE: LFC; HKSE: 2628; SSE: 601628) announced that the shareholders of the Company approved the appointment of Ernst & Young as the Companys independent registered certified public accountant at the extraordinary general meeting held today.] [Description 99.1 Announcement, dated February 19, 2013 99.2 Press release, dated February 19, 2013]
LFC [CHINA LIFE INSURANCE CO] 6-K: CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock
[CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the Peoples Republic of China with limited liability) (Stock Code: 2628) ANNOUNCEMENT OF THE RESOLUTIONS PASSED AT THE FIRST EXTRAORDINARY GENERAL MEETING 2013 Board Company EGM The board of directors (the The EGM was held on Tuesday, 19 February 2013 at 10:00 a.m. at Multi-function Hall, 2/F,] [China Life Appoints New Auditor (Beijing, China, February 19, 2013) The board of directors (the Board) of China Life Insurance Company Limited (the Company) (NYSE: LFC; HKSE: 2628; SSE: 601628) announced that the shareholders of the Company approved the appointment of Ernst & Young as the Companys independent registered certified public accountant at the extraordinary general meeting held today.] [Description 99.1 Announcement, dated February 19, 2013 99.2 Press release, dated February 19, 2013]
